Molecular Description of Familial Defective APOB-100 in Malaysia

被引:6
|
作者
Al-Khateeb, Alyaa R. [1 ,2 ]
Mohd, Mohd Sapawi [3 ]
Yusof, Zukarnai [4 ]
Zilfalil, Bin Alwi [2 ]
机构
[1] Univ Teknol MARA UiTM, Fac Med, Jalan Hosp, Sungai Buloh 47000, Selangor, Malaysia
[2] Univ Sains Malaysia, Sch Med Sci, Ctr Human Genome, Kubang Kerian 16150, Kelantan, Malaysia
[3] Hosp Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia
[4] Univ Sains Malaysia, Sch Med Sci, Dept Med, Kubang Kerian 16150, Kelantan, Malaysia
关键词
APOB-100; gene; Familial defective APOB-100; Mutation; DHPLC; LIPOPROTEIN RECEPTOR GENE; APOLIPOPROTEIN B-100; B GENE; APO-B; MUTATION; HYPERCHOLESTEROLEMIA; IDENTIFICATION;
D O I
10.1007/s10528-013-9609-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial ligand-defective apolipoprotein B-100 is characterized by elevated plasma low-density lipoprotein levels and premature heart disease. This study aims to determine apolipoprotein B gene mutations among Malaysians with clinical diagnoses of familial hypercholesterolemia and to compare the phenotype of patients with apolipoprotein B gene mutations to those with a low-density lipoprotein receptor gene mutation. A group of 164 patients with a clinical diagnosis of familial hypercholesterolemia was analyzed. Amplicons in exon 26 and exon 29 of the apolipoprotein B gene were screened for genetic variants using denaturing gradient high-performance liquid chromatography; 10 variants were identified. Five novel mutations were detected (p.Gln2485Arg, p.Thr3526Ala, p.Glu3666Lys, p.Tyr4343CysfsX221, and p.Arg4297His). Those with familial defective apolipoprotein had a less severe phenotype than those with familial hypercholesterolemia. An apolipoprotein gene defect is present among Malaysian familial hypercholesterolemics. Those with both mutations show a more severe phenotype than those with one gene defect.
引用
收藏
页码:811 / 823
页数:13
相关论文
共 50 条
  • [1] Molecular Description of Familial Defective APOB-100 in Malaysia
    Alyaa R. Al-Khateeb
    Mohd Sapawi Mohd
    Zukarnai Yusof
    Bin Alwi Zilfalil
    Biochemical Genetics, 2013, 51 : 811 - 823
  • [2] Familial defective APOB-100 in Slovak patients with primary hypercholesterolemia
    Raslova, K
    Gasparovic, J
    Franekova, J
    Fabryova, L
    Kovac, G
    Stavny, J
    Rajecova, E
    Belosovicova, M
    Babjak, M
    Vohnout, B
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 59 - 59
  • [3] Subjects with Molecularly Defined Familial Hypercholesterolemia or Familial Defective apoB-100 Are Not Being Adequately Treated
    Leren, Trond P.
    Berge, Knut Erik
    PLOS ONE, 2011, 6 (02):
  • [4] Increased production of HDL ApoA-I in homozygous familial defective ApoB-100
    Schaefer, JR
    Winkler, K
    Schweer, H
    Hoffmann, MM
    Soufi, M
    Scharnagl, H
    Maisch, B
    Wieland, H
    Steinmetz, A
    März, W
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) : 1796 - 1799
  • [5] Metabolism of apoB-100 in familial hypobetalipoproteinemia (FHBL) with and without genetically determined truncated forms of apoB
    Latour, MA
    Patterson, BW
    Pulai, J
    Schonfeld, G
    CIRCULATION, 1996, 94 (08) : 3413 - 3413
  • [6] Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia
    Verseyden, C
    Meijssen, S
    Cabezas, MC
    JOURNAL OF LIPID RESEARCH, 2002, 43 (02) : 274 - 280
  • [7] Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia
    Elias, N
    Patterson, BW
    Schonfeld, G
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) : 2714 - 2721
  • [8] H3543Y mutation of apoB-100 in patients with phenotype of familial hypercholesterolemia
    Basistova, Zuzana
    Gasparovic, Juraj
    Sivakova, Daniela
    Raslova, Katarina
    ATHEROSCLEROSIS, 2007, 194 (02) : E185 - E187
  • [9] Missense mutations in APOB within the βα1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia
    Burnett, John R.
    Zhong, Shumei
    Jiang, Zhenghui G.
    Hooper, Amanda J.
    Fisher, Eric A.
    McLeod, Roger S.
    Zhao, Yang
    Barrett, P. Hugh R.
    Hegele, Robert A.
    van Bockxmeer, Frank M.
    Zhang, Hongyu
    Vance, Dennis E.
    McKnight, C. James
    Yao, Zemin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (33) : 24270 - 24283
  • [10] Inhibition of human ApoB-100 in transgenic mice
    Graham, MJ
    Lemonidis, KM
    Whipple, C
    Petinos, N
    Crooke, RM
    CIRCULATION, 2003, 108 (17) : 177 - 177